Related references
Note: Only part of the references are listed.Imaging cancer using PET - the effect of the bifunctional chelator on the biodistribution of a Cu-64-labeled antibody
Jason L. J. Dearling et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
A comparison of In-111- or Cu-64-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT
Conrad Chan et al.
EJNMMI RESEARCH (2011)
The Remarkable Stability of Chimeric, Sialic Acid-derived α/δ-Peptides in Human Blood Plasma
Jonel P. Saludes et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies)
Tove Olafsen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
Flavio Forrer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
Mark P. S. Dunphy et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
18F-FDOPA: A Multiple-Target Molecule
Heikki Minn et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Eli C. F. Dijkers et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies
Lin Li et al.
BIOCONJUGATE CHEMISTRY (2008)
Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas
David J. Betting et al.
JOURNAL OF IMMUNOLOGY (2008)
Drug therapy: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma
Bruce D. Cheson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy
Xuhui Zhou et al.
ONCOLOGIST (2008)
Development of [64Cu]-DOTA-anti-CD20 for targeted therapy
A. R. Jalilian et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2007)
Mechanisms of killing by anti-CD20 monoclonal antibodies
Martin J. Glennie et al.
MOLECULAR IMMUNOLOGY (2007)
MicroPET-based biodistribution of quantum dots in living mice
Meike L. Schipper et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Depletion of B cells in murine lupus: Efficacy and resistance
Anupama Ahuja et al.
JOURNAL OF IMMUNOLOGY (2007)
The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-PET with 67gallium scintigraphy in the evaluation of lymphoma -: Relation to histologic subtypes-based on the World Health Organization Classification
Norifumi Tsukamoto et al.
CANCER (2007)
Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies
Rakesh Dixit et al.
DRUG DISCOVERY TODAY (2007)
Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas
Maroun Karam et al.
CANCER (2006)
Current concepts - Positron-emission tomography and assessment of cancer therapy
ME Juweid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
In vivo evaluation of 177Lu- and 67/64Cu-labelled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors
J Grünberg et al.
CLINICAL CANCER RESEARCH (2005)
Mass spectral analyses of labile DOTA-NHS and heterogeneity determination of DOTA or DM1 conjugated anti-PSMA antibody for prostate cancer therapy
SX Lu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy
Q Gong et al.
JOURNAL OF IMMUNOLOGY (2005)
Physical models and dose factors for use in internal dose assessment
MG Stabin et al.
HEALTH PHYSICS (2003)
Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N′,N,N′-tetraacetic acid for radiolabeling proteins
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
Targeting of renal carcinoma with 67/64CU-labeled anti-L1-CAM antibody chCE7:: selection of copper ligands and PET imaging
K Zimmermann et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
High-resolution microPET imaging of carcino-embryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
AM Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes Pb-203 and Pb-212
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Share Paper
